224 related articles for article (PubMed ID: 17497014)
1. Structure-Activity Relationships of Synthetic Coumarins as HIV-1 Inhibitors.
Kostova I; Raleva S; Genova P; Argirova R
Bioinorg Chem Appl; 2006; 2006():68274. PubMed ID: 17497014
[TBL] [Abstract][Full Text] [Related]
2. Coumarins as inhibitors of HIV reverse transcriptase.
Kostova I
Curr HIV Res; 2006 Jul; 4(3):347-63. PubMed ID: 16842086
[TBL] [Abstract][Full Text] [Related]
3. Coumarin-based derivatives with potential anti-HIV activity.
Xu Z; Chen Q; Zhang Y; Liang C
Fitoterapia; 2021 Apr; 150():104863. PubMed ID: 33582266
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in the development of coumarin derivatives as potent anti-HIV agents.
Yu D; Suzuki M; Xie L; Morris-Natschke SL; Lee KH
Med Res Rev; 2003 May; 23(3):322-45. PubMed ID: 12647313
[TBL] [Abstract][Full Text] [Related]
5. Coumarins as Potential Inhibitors of DNA Polymerases and Reverse Transcriptases. Searching New Antiretroviral and Antitumoral Drugs.
Garro HA; Pungitore CR
Curr Drug Discov Technol; 2015; 12(2):66-79. PubMed ID: 26179474
[TBL] [Abstract][Full Text] [Related]
6. Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase.
Zhu M; Ma L; Wen J; Dong B; Wang Y; Wang Z; Zhou J; Zhang G; Wang J; Guo Y; Liang C; Cen S; Wang Y
Eur J Med Chem; 2020 Jan; 186():111900. PubMed ID: 31771827
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
[TBL] [Abstract][Full Text] [Related]
8. [Progress in the new nonnucleoside anti-HIV reverse transcriptase inhibitor-DCK].
Guo HF; Xie L
Yao Xue Xue Bao; 2008 Oct; 43(10):997-1002. PubMed ID: 19127862
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents.
Kulkarni MV; Kulkarni GM; Lin CH; Sun CM
Curr Med Chem; 2006; 13(23):2795-818. PubMed ID: 17073630
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives.
Huang L; Yuan X; Yu D; Lee KH; Chen CH
Virology; 2005 Feb; 332(2):623-8. PubMed ID: 15680427
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in the development of inhibitors of human immunodeficiency virus (HIV) integrase for the management of HIV infection.
Lin SS; Xu F; Liao PH; Yang CC
Acta Virol; 2008; 52(4):197-207. PubMed ID: 19143475
[TBL] [Abstract][Full Text] [Related]
12. Current peptide HIV type-1 fusion inhibitors.
Pang W; Tam SC; Zheng YT
Antivir Chem Chemother; 2009 Sep; 20(1):1-18. PubMed ID: 19794228
[TBL] [Abstract][Full Text] [Related]
13. Chemical modification of coumarin dimer and HIV-1 integrase inhibitory activity.
Mao PC; Mouscadet JF; Leh H; Auclair C; Hsu LY
Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1634-7. PubMed ID: 12499608
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
15. Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments.
Gill MSA; Hassan SS; Ahemad N
Eur J Med Chem; 2019 Oct; 179():423-448. PubMed ID: 31265935
[TBL] [Abstract][Full Text] [Related]
16. Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.
Esposito F; Ambrosio FA; Maleddu R; Costa G; Rocca R; Maccioni E; Catalano R; Romeo I; Eleftheriou P; Karia DC; Tsirides P; Godvani N; Pandya H; Corona A; Alcaro S; Artese A; Geronikaki A; Tramontano E
Eur J Med Chem; 2019 Nov; 182():111617. PubMed ID: 31442684
[TBL] [Abstract][Full Text] [Related]
17. Coumarins: old compounds with novel promising therapeutic perspectives.
Riveiro ME; De Kimpe N; Moglioni A; Vázquez R; Monczor F; Shayo C; Davio C
Curr Med Chem; 2010; 17(13):1325-38. PubMed ID: 20166938
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and HIV-1 integrase inhibition of novel bis- or tetra-coumarin analogues.
Chiang CC; Mouscadet JF; Tsai HJ; Liu CT; Hsu LY
Chem Pharm Bull (Tokyo); 2007 Dec; 55(12):1740-3. PubMed ID: 18057750
[TBL] [Abstract][Full Text] [Related]
19. The structure and pharmacological functions of coumarins and their derivatives.
Wu L; Wang X; Xu W; Farzaneh F; Xu R
Curr Med Chem; 2009; 16(32):4236-60. PubMed ID: 19754420
[TBL] [Abstract][Full Text] [Related]
20. Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication.
Buckheit RW; Russell JD; Xu ZQ; Flavin M
Antivir Chem Chemother; 2000 Sep; 11(5):321-7. PubMed ID: 11142630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
